Immunitybio alert: bragar eagel & squire, p.c. announces that a class action lawsuit has been filed against immunitybio, inc. and encourages investors to contact the firm

New york--(business wire)-- #action--bragar eagel & squire, p.c., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against immunitybio, inc. (“immunitybio” or the “company”) (nasdaq: ibrx) in the united states district court for the southern district of california on behalf of all persons and entities who purchased or otherwise acquired immunitybio securities between may 23, 2022 and may 10, 2023, both dates inclusive (the “class period”). inve.
IBRX Ratings Summary
IBRX Quant Ranking